Shop
eStoreRx™
Online Supplement Dispensary
Easy direct-to-patient ordering & fulfilment for Lifelong Wellness, eStoreRx™ is offered as part of the WholePractice membership or as a stand-alone program.
For over 40 years, Biotics Research Corporation has revolutionized the nutritional supplement industry by utilizing “The Best of Science and Nature”. Combining nature’s principles with scientific ingenuity, our products magnify the nutritional
This inclusive membership contains all of the the tools you need to grow your business, including WholeLifeRx™, Nimativ®, WholeLifeQ™, eStoreRx™ and Practice Success Programs.
Easy direct-to-patient ordering & fulfilment for Lifelong Wellness, eStoreRx™ is offered as part of the WholePractice membership or as a stand-alone program.
April 11 2024
A report on the intake of fish and omega-3 fatty acids among pregnant women in the U.S. was recently published in Public Health Nutrition. This analys...
Research has demonstrated that low serum vitamin D can cause myalgia, myositis, myopathy, and myonecrosis. Statin-induced myalgia is a major and common cause of statin intolerance. In a study of 146 adults with myalgia related statin intolerance found to have low (<32 ng/mL) serum vitamin D, researchers prospectively assessed whether vitamin D supplementation to normalize serum vitamin D would allow successful re-challenge therapy with statins. Median serum vitamin D levels at entry in the 24 month study was 22-23 ng/mL, and rose at 6, 12, and 24 months to 53-55 ng/mL, normalizing in 95% of patients after 24 months following vitamin D therapy. On the 6, 12 and 24 month follow-up on re-challenged patients on statins and vitamin D, 88%, 91% and 95% of the previously statin-intolerant patients, respectively, were free of myalgia, myositis, myopathy, and/or myonecrosis! Before beginning the study, all the patients had experience myalgia, myositis, myopathy, or myonecrosis on statins (predominantly simvastatin, atorvastatin or lovastatin). This current study supports the findings of three previous studies associating statin related myalgias with low serum vitamin D status. By providing supplemental vitamin D to statin-intolerant patients with low serum vitamin D at entry, 88% were subsequently able to tolerate re-challenge with stains with excellent tolerability, and the LDLC lowering to targeted levels. Researchers concluded that statin intolerance because of myalgia, myositis, myopathy, or myonecrosis in vitamin D deficient patients can, in most cases (88%-95%)be safely resolved by vitamin D supplementation!
Khayznikov M, et al. Statin Intolerance Because of Myalgia, Myositis, Myopathy, or Myonecrosis Can in Most Cases be Safely Resolved by Vitamin D supplementation. N Am J Med Sci. 2015 Mar; 7(3): 86-93.
Submit this form and you'll receive our latest news and updates.
*These statements have not been evaluated by the Food and Drug Administration. This product has not intended to diagnose, treat, cure, or prevent any disease.
© 2023 Biotics Research Corporation - All Rights Reserved
Submit your comment